Candidemia in an Immunocompromised Patient

Authors

  • Lakshmi Jyothi Microbiology, All India Institute of Medical Sciences, Hyderabad, India.
  • Naveen P. Reddy General Medicine, Mediciti Institute of Medical Sciences, Hyderabad, India.
  • Shazia Naaz Microbiology, Employees' State Insurance Corporation (ESIC) Medical College & Hospital, Sananthnagar, Hyderabad, India.

DOI:

https://doi.org/10.9734/bpi/nhmmr/v11/1627A

Keywords:

Candidemia, immunocompromised, Candida species, fluconazole, haemodialysis, Candida kefyr

Abstract

An immunocompromised patient with a known history of cerebrovascular accident (CVA) with right-sided hemiparesis of long duration, type 2 diabetes mellitus, and hypertension presented with signs of rhabdomyolysis and later acute kidney injury (AKI). He subsequently developed Guillain Barre syndrome.

Initially, haemodialysis was followed by plasmapheresis. After haemodialysis, the patient presented with multiple episodes of vomiting and weakness of all limbs. A culture showed growth of Enterococcus faecalis, and on Day 6, a bloodstream infection with Candida kefyr and a urinary tract infection with Enterococcus faecalis was diagnosed. We report a rare case of bloodstream infection due to C. kefyr. The patient recovered and was discharged successfully with continuous follow-up for the next six months.

Published

2022-06-10

How to Cite

Lakshmi Jyothi, Naveen P. Reddy, & Shazia Naaz. (2022). Candidemia in an Immunocompromised Patient. New Horizons in Medicine and Medical Research Vol. 11, 150–153. https://doi.org/10.9734/bpi/nhmmr/v11/1627A